An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol
Clinical trial NCT01739764 · COMPLETED
Trial details
- NCT number
- NCT01739764
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-19
- Primary completion
- 2020-02-17
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.